NCT07325344 Active Locomotion of Magnetically Controlled Capsule Endoscopy in the Small Bowel: A Feasibility Study
| NCT ID | NCT07325344 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shandong University |
| Condition | Capsule Endoscopy |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2025-12-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the responsiveness of the capsule endoscope to the attitude controller and to investigate its active locomotion performance within the small bowel.
Eligibility Criteria
Inclusion Criteria: * Patients scheduled to undergo enteroscopy. Exclusion Criteria: * Patients with severe dysfunction of vital organs (e.g., heart, lungs). Patients with small bowel obstruction precluding adequate bowel preparation. Patients with a history of multiple abdominal surgeries. Patients with implanted devices such as cardiac pacemakers or metal implants. Patients with other high-risk conditions or lesions (e.g., moderate-to-severe esophagogastric varices, massive ascites). Patients who are pregnant or lactating. Patients unable or unwilling to provide informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07325344 clinical trial?
This trial is open to participants of all sexes, studying Capsule Endoscopy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07325344 currently recruiting?
Yes, NCT07325344 is actively recruiting participants. Contact the research team at zuoxiuli@sdu.edu.cn for enrollment information.
Where is the NCT07325344 trial being conducted?
This trial is being conducted at Jinan, China.
Who is sponsoring the NCT07325344 clinical trial?
NCT07325344 is sponsored by Shandong University. The trial plans to enroll 15 participants.